Skip to main content

GRI Bio, Inc.

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

GRI$1.89+10.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Page
PART I.FINANCIAL INFORMATION3
Item 1.Financial Statements3
Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 20243
Consolidated Statements of Operations (unaudited) for the three months ended March 31, 2025 and 20244
Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the three months ended March 31, 2025 and 20245
Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2025 and 20246
Notes to Unaudited Interim Consolidated Financial Statements7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations17
Item 3.Quantitative and Qualitative Disclosures About Market Risk22
Item 4.Controls and Procedures23
PART II.OTHER INFORMATION24
Item 1.Legal Proceedings24
Item 1A.Risk Factors24
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds24
Item 3.Defaults Upon Senior Securities24
Item 4.Mine Safety Disclosures24
Item 5.Other Information24
Item 6.Exhibits25
Signatures26

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.